Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

Abstract:  The heat‐shock protein Hsp90 has been shown to be essential for the functional integrity of the telomerase complex. The telomerase activity is enhanced in melanoma and stabilizes the chromosomal integrity in proliferating cells. Furthermore, overexpression of Hsp90 induces silencing of point mutations in transcription factors which, otherwise, would result in a loss‐of‐function phenotype. In melanocytic lesions there is a higher risk of mutations caused by the enhanced proliferation in melanocytic cells. By analyzing microdissected melanocytic tumors by semiquantitative PCR, we demonstrate an overexpression of Hsp90 mRNA in malignant melanomas (10/14) and in melanoma metastases (6/6) as well as in melanoma cell lines (9/9) when compared with melanocytic nevi (2/9). These results could be confirmed on protein level by immunohistochemistry. While melanocytic nevi show discrete Hsp90 expression only in a minor fraction (2/9), malignant melanomas and metastases show a positive Hsp90 immunohistochemistry in the majority of cases; (7/9) and (13/14), respectively. In addition, by analyzing melanoma metastases by flow cytometry we show that Hsp90 is expressed on the surface of tumor cells (7/8). From these data we conclude that Hsp90 is present in advanced malignant melanomas and may have a stabilizing effect on the cellular functions in proliferating cells of melanocytic lesions and could thereby be a prerequisite for the tumor progression. As Hsp90 is expressed on the cell surface, it might also be a potential immunorelevant target structure for immunotherapy of melanoma.

[1]  M. Landthaler,et al.  Heat shock protein 70 membrane expression and melanoma‐associated marker phenotype in primary and metastatic melanoma , 2003, Melanoma research.

[2]  S. Lindquist,et al.  Hsp90 as a capacitor of phenotypic variation , 2002, Nature.

[3]  W. Hiddemann,et al.  A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity , 2001, Cell stress & chaperones.

[4]  P. Nelson,et al.  A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression. , 2001, Cancer research.

[5]  W. Stolz,et al.  Detection of differentially regulated genes in keratinocytes by cDNA array hybridization: Hsp27 and other novel players in response to artificial ultraviolet radiation. , 2001, Journal of Investigative Dermatology.

[6]  W. Hait,et al.  Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin. , 2001, Cancer research.

[7]  L Rensing,et al.  Chaperones in cell cycle regulation and mitogenic signal transduction: a review , 2000, Cell proliferation.

[8]  P. Srivastava,et al.  Saturation, Competition, and Specificity in Interaction of Heat Shock Proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ Cells1 , 2000, The Journal of Immunology.

[9]  P. Srivastava,et al.  CD91: a receptor for heat shock protein gp96 , 2000, Nature Immunology.

[10]  Philippe Daelemans,et al.  Expression des protéines de choc thermique dans les tumeurs des glandes salivaires: Etude immunohistochimique des HSP27, HSP70, HSP90 et HSP110 : à propos de 50 cas , 2000 .

[11]  P. Daelemans,et al.  [Expression of heat shock proteins in salivary gland tumors. Immunohistochemical study of HSP27, HSP70, HSP90, and HSP110: apropos of 50 cases]. , 2000, Annales de pathologie.

[12]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[13]  L. Pearl,et al.  Structure and in vivo function of Hsp90. , 2000, Current opinion in structural biology.

[14]  H. Kampinga,et al.  Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. , 1999, Experimental hematology.

[15]  H. Rammensee,et al.  Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. , 1999, Journal of immunology.

[16]  G. Morin,et al.  Functional requirement of p23 and Hsp90 in telomerase complexes. , 1999, Genes & development.

[17]  Z. Naito,et al.  Expression of hsp90 and cyclin D1 in human breast cancer. , 1999, Cancer letters.

[18]  H. Rammensee,et al.  Stress proteins and immunity mediated by cytotoxic T lymphocytes. , 1999, Current opinion in immunology.

[19]  W. Stolz,et al.  Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas , 1999, Archives of Dermatological Research.

[20]  L. Whitesell,et al.  Molecular chaperones: biology and prospects for pharmacological intervention. , 1998, Pharmacological reviews.

[21]  S. Lindquist,et al.  Hsp90 as a capacitor for morphological evolution , 1998, Nature.

[22]  P. Srivastava,et al.  Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. , 1998, Immunity.

[23]  Sreenath V. Sharma,et al.  Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol , 1998, Oncogene.

[24]  W. Stolz,et al.  Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  K. Irie,et al.  Radicicol Leads to Selective Depletion of Raf Kinase and Disrupts K-Ras-activated Aberrant Signaling Pathway* , 1998, The Journal of Biological Chemistry.

[26]  I. Konishi,et al.  Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. , 1998, Cancer detection and prevention.

[27]  W. Pratt,et al.  Folding of the Glucocorticoid Receptor by the Reconstituted hsp90-based Chaperone Machinery , 1997, The Journal of Biological Chemistry.

[28]  R. Issels,et al.  Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. , 1997, Journal of immunology.

[29]  D. J. Barrett,et al.  Hsp90-mediated folding of the lymphoid cell kinase p56lck. , 1996, Biochemistry.

[30]  Mikhail V. Blagosklonny,et al.  Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras Association (*) , 1995, The Journal of Biological Chemistry.

[31]  A. Bolognesi,et al.  In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells. , 1995, Journal of biological regulators and homeostatic agents.

[32]  M. Ferrarini,et al.  Constitutive expression of the heat shock protein 72 kDa in human melanoma cells. , 1994, Cancer letters.

[33]  L. Neckers,et al.  Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Matts,et al.  Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. , 1994, Biochemistry.

[35]  J. Gustafsson,et al.  The Mr approximately 90,000 heat shock protein: an important modulator of ligand and DNA-binding properties of the glucocorticoid receptor. , 1989, Cancer research.